General information: This rare syndrome is caused by germline mutations of the CDKN1B (cyclin-dependent kinase inhibitor 1B) tumor-suppressor gene and is characterized by the association of primary hyperparathyroidism and pituitary, renal, and adrenal tumors. Here, CDKN1B is linked to primary hyperparathyroidism.